NVDA+0.84%AAPL−2.51%GOOGL−1.17%MSFT−2.04%AMZN−0.15%TSM+2.85%SPCX−1.20%AVGO+0.21%
StockVS

NASDAQ · Medical Care Facilities · USD

Strata Critical Medical, Inc. (SRTA) Stock Analysis

Strata Critical Medical, Inc. (SRTA) is a Medical Care Facilities stock listed on NASDAQ and quoted in US Dollar.

SRTA

$5.32

−$0.05 (−0.93%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare SRTA with… →

SRTA Key Statistics

As of Sep 4, 2026
Trading
Open
$5.34
Previous Close
$5.37
Day's Range
5.31–5.43
52-Week Range
3.85–6.50
Volume
650.30K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
2.26
Valuation
Market Cap
$470.64M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.84
EPS (ttm)Profit attributable to each share over the last twelve months.
−0.28
Financials (FY)
Revenue (FY)
$197.14M+34.28%
Net Income (FY)
$41.35M
Profit marginThe share of revenue left as profit after all costs and taxes.
15.71%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
88.47M
1-Year Return
+27.27%
Dividend and dates
Earnings Date
November 9, 2026
Avg Volume
1.15M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

SRTA Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)+10.60%
2025+13.18%
2024+20.40%
2023−1.40%
2022−59.46%
2021−20.31%
2020+12.72%
2019 (partial year)+0.82%

As of September 4, 2026.

SRTA Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$197.14M$41.35M21.0%
2024$146.82M−$27.31M−18.6%
2023$225.18M−$56.08M−24.9%
2022$146.12M−$27.26M−18.7%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$197.14M$41.13M−$22.35M$41.35M21.0%
2024$146.82M$29.59M−$22.53M−$27.31M−18.6%
2023$225.18M$42.12M−$68.12M−$56.08M−24.9%
2022$146.12M$22.28M−$53.53M−$27.26M−18.7%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

SRTA Valuation vs Medical Care Facilities Median

Median of 57 stocks
MetricSRTAMedical Care Facilities medianvs median
P/S ratio1.840.9593% above
Profit margin15.71%3.06%12.7 pts above

Medians across 57 Medical Care Facilities stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 9 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Strata Critical Medical, Inc. (SRTA) carries a market capitalisation of $470.64M. It is classified in the Medical Care Facilities industry, within the Healthcare sector. The company reports 327 employees.

The 52-week range on file runs from $3.85 to $6.50. SRTA last closed at $5.32 on September 4, 2026. That is −$0.05 (−0.93%) against the previous close. The latest close sits 38.18% above that 52-week low.

Financial Health

The most recent full year on file, fiscal 2025, shows revenue of $197.14M. Against the prior fiscal year total of $146.82M, that is a change of +34.28%. The same year closed with net income of $41.35M. The reported profit margin is 15.71%. That is 12.7 percentage points above the Medical Care Facilities median of 3.06%. Trailing earnings per share are −0.28.

Across the 4 fiscal years on file, revenue moves from $146.12M in 2022 to $197.14M in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. Measured against sales, the shares trade at 1.84 times revenue. On price-to-sales that is 93.45% above the Medical Care Facilities median of 0.95. 57 Medical Care Facilities companies report these metrics, and the medians quoted come from that group.

The trailing one-year price return is +27.27%. Measured over 5 years, that is −9.68% a year compounded. Beta against the wider market is reported at 2.26. Annualized volatility over the trailing 6 years is 66.7%.

Growth & Income

No dividend is on file for SRTA.

2026 is still running; the price is +10.60% year to date. The strongest complete calendar year on file is 2024 at +20.40%; the weakest is 2022 at −59.46%. Of the 6 complete calendar years on file, 3 finished higher.

Peer Comparison

Strata Critical Medical, Inc. (SRTA) operates in the Medical Care Facilities industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Strata Critical Medical, Inc. SRTA $470.64M —
HCA Healthcare, Inc. HCA $87.68B 13.6
Tenet Healthcare Corporation THC $21.34B 10.2
Fresenius Medical Care AG FMS $12.06B 11.7

The Medical Care Facilities industry average P/E ratio is 19.8x. Strata Critical Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Care Facilities Stocks

HCA

HCA Healthcare, Inc.

$87.68B

 THC

Tenet Healthcare Corporation

$21.34B

 FMS

Fresenius Medical Care AG

$12.06B

 EHC

Encompass Health Corporation

$12.01B

 DVA

DaVita Inc.

$11.74B

 UHS

Universal Health Services, Inc.

$10.00B
View all Medical Care Facilities stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.02T

 JNJ

Johnson & Johnson

$663.28B

 ABBV

AbbVie Inc.

$453.19B

 MRK

Merck & Co., Inc.

$370.89B

 UNH

UnitedHealth Group Incorporated

$356.47B
View all Healthcare stocks →

About Strata Critical Medical, Inc.

Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground transportation for human organs, transplant teams, and related medical materials and organ placement services; transplant clinical services, including organ recovery procedures, normothermic regional perfusion, and preservation services. It also provides other clinical services comprising cardiac perfusion services, blood management and autotransfusion services, extracorporeal membrane oxygenation services, perfusion staffing, and equipment rentals. The company was formerly known as Blade Air Mobility, Inc. and changed its name to Strata Critical Medical, Inc. in August 2025. The company was founded in 2014 and is headquartered in New York, New York.

Visit website →